维普期刊资源整合服务平台（V6.5）

22篇 您的检索式：作者名="Hézode"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Long-term hepatitis B surface antigen(HBsAg) kinetics during nucleoside/nucleotide analogue therapy:finite treatment duration unlikely显示文摘	Chevaliez S Hézode C Bahrami S	2013	J Hepatol2013，58，：	1
2	Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC)-NCT01514890显示文摘	Hézode C Fontaine H Dorival C	2013	J Hepatol2013，59，3：	1
3	Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C显示文摘	Hézode C Roudot-Thoraval F Nguyen S		0，，1：	1
4	Ideal oral combinations to eradicate HCV: The role of ribavirin显示文摘	Christophe Hézode Jean-Pierre Bronowicki	2015	Journal of Hepatology2015，，：	1
5	Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: Finite treatment duration unlikely显示文摘	Stéphane Chevaliez Christophe Hézode Stéphane Bahrami Marion Grare Jean-Michel Pawlotsky	2012	Journal of Hepatology2012，，：	2
6	Antiviral strategies in hepatitis C virus infection显示文摘	Christoph Sarrazin Christophe Hézode Stefan Zeuzem Jean-Michel Pawlotsky	2012	Journal of Hepatology2012，，：	2
7	Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial 显示文摘	Hézode C Asselah T Reddy KR	2015	Lancet2015，385，：	1
8	Antiviral strategies in hepatitis C virus infection显示文摘	Christoph Sarrazin Christophe Hézode Stefan Zeuzem Jean-Michel Pawlotsky	2012	Journal of Hepatology2012，，：	1
9	Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection 显示文摘	Feld JJ Jacobson IM Hézode C	2015	N Engl J Med2015，373，：	1
10	Telaprevir and poginterferon with or without ribavirin for chronic HCV infection显示文摘	Hézode C Forestier N Dusheiko G	2009	N Engl J Med2009，360，18：	1
11	Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C显示文摘	Hézode C Roudot-Thoraval F Nguyen S	2005	Hepatology2005，42，1：	1
12	Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies显示文摘	Castéra L Hézode C Roudot-Thoraval F		0，，：	1
13	每日吸食大麻是慢性丙型肝炎患者肝纤维化进展的危险因素	Hézode C. Roudot-Thoraval F. Nguyen S. A. Mallat 李翔	2005	世界核心医学期刊文摘(胃肠病学分册)2005，0，10：	0
14	Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients显示文摘	Keyur Patel Stuart C. Gordon Ira Jacobson Christophe Hézode Esther Oh Katie M. Smith Jean-Michel Pawlotsky John G. McHutchison	2004	Journal of Hepatology2004，，6：	1
15	How to optimize HCV therapy in genotype 1 patients with cirrhosis显示文摘	Marc Bourlière Astrid Wendt Hélène Fontaine Christophe Hézode Stanislas Pol Jean Pierre Bronowicki	2013	Liver Int2013，，：	1
16	Risk factors for lymphoproliferative disorders after liver transplantation in adults: an analysis of 480 patients显示文摘	Christophe Duvoux Georges-Philippe Pageaux Claire Vanlemmens Fran?oise Roudot-Thoraval Anne-Laure Vincens-Rolland Christophe Hézode Philippe Gaulard Jean-Philippe Miguet Dominique Larrey Daniel Dhumeaux Daniel Cherqui	2002	Transplantation2002，，8：	1
17	Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation显示文摘	Christophe Hézode Christophe Duvoux Georgios Germanidis Fran?oise Roudot‐Thoraval Anne‐Laure Vincens Philippe Gaulard Daniel Cherqui Jean‐Michel Pawlotsky Daniel Dhumeaux	2003	Hepatology2003，，3：	1
18	Dermatological side effects of hepatitis C and its treatment: Patient management in the era of direct-acting antivirals显示文摘	Patrice Cacoub Marc Bourlière Jann Lübbe Nicolas Dupin Peter Buggisch Geoffrey Dusheiko Christophe Hézode Odile Picard Ramon Pujol Siegfried Segaert Bing Thio Jean-Claude Roujeau	2011	Journal of Hepatology2011，，2：	1
19	Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890<!-- Doctopic: VH -->显示文摘	Christophe Hézode Hélène Fontaine Céline Dorival Dominique Larrey Fabien Zoulim Valérie Canva Victor de Ledinghen Thierry Poynard Didier Samuel Marc Bourlière Jean-Pierre Zarski Jean-Jacques Raabe Laurent Alric Patrick Marcellin Ghassan Riachi Pierre-Henr	2013	Journal of Hepatology2013，，：	2
20	Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890<!-- Doctopic: VH -->显示文摘	Christophe Hézode Hélène Fontaine Céline Dorival Dominique Larrey Fabien Zoulim Valérie Canva Victor de Ledinghen Thierry Poynard Didier Samuel Marc Bourlière Jean-Pierre Zarski Jean-Jacques Raabe Laurent Alric Patrick Marcellin Ghassan Riachi Pierre-Henr	2013	Journal of Hepatology2013，，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示